Dianthus Therapeutics
€72.5
9
+€0.5+0.69% Wednesday 06:05
Statistics
Day High
68.5
Day Low
68.5
52W High
72.5
52W Low
13
Volume
-
Avg. Volume
-
Mkt Cap
3.11B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
7MayExpected
Expected EPS
-0.9206693335
Actual EPS
N/A
Financials
-1,366.9%Profit Margin
Unprofitable11.8MRevenue
-161.34MNet Income
Analyst Ratings
$96.06Average Price Target
The highest estimate is 151.76.
From 10 ratings within the last 6 months. This is not an investment recommendation.
From 10 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 87E.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases. It develops DNTH103 that is in phase 1 clinical trails in patients with generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was incorporated in 2015 and is based in New York, New York.
Show more...
CEO
ISIN
US2528281080
WKN
000A3ERZ4
Listings
0 Comments
Share your thoughts
FAQ
What is Dianthus Therapeutics stock price today?▼
The current price of 87E.F is €72.5 EUR — it has increased by +0.69% in the past 24 hours. Watch Dianthus Therapeutics stock price performance more closely on the chart.
What is Dianthus Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Dianthus Therapeutics stocks are traded under the ticker 87E.F.
Is Dianthus Therapeutics stock price growing?▼
87E.F stock has risen by +0.69% compared to the previous week, the month change is a +67.82% rise, over the last year Dianthus Therapeutics has showed a +367.74% increase.
What is Dianthus Therapeutics market cap?▼
Today Dianthus Therapeutics has the market capitalization of 3.11B
When is the next Dianthus Therapeutics earnings date?▼
Dianthus Therapeutics is going to release the next earnings report on May 07, 2026.
What were Dianthus Therapeutics earnings last quarter?▼
87E.F earnings for the last quarter are -1.23 EUR per share, whereas the estimation was -0.87 EUR resulting in a -42.17% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Dianthus Therapeutics revenue for the last year?▼
Dianthus Therapeutics revenue for the last year amounts to 11.8M EUR.
What is Dianthus Therapeutics net income for the last year?▼
87E.F net income for the last year is -161.34M EUR.
When did Dianthus Therapeutics complete a stock split?▼
The last stock split for Dianthus Therapeutics was on September 12, 2023 with a ratio of 1:16.